June 04, 2012
Abbott Laboratories on Friday continued its crusade to protect its cholesterol drug Niaspan by filing a lawsuit against Kremers Urban Pharmaceuticals Inc., accusing the company of infringing Abbott's patents through its efforts to market a generic version of the drug.